DMS • 1 Rope Ferry Road • Hanover, NH 03755-1404 • Voice 603 650-1200 • Fax 603 650-1202 • Toll Free 1 877 DMS 1797

| | |

George A. O'Toole, Ph.D.

Title(s):
Associate Professor of Microbiology and Immunology

Department(s):
Microbiology and Immunology

Education:
University of Wisconsin - Madison, Ph.D., 1994
Cornell University, B.S., 1988

After postdoctoral work at the University of Wisconsin-Madison and Harvard Medical School, Dr. O'Toole joined the faculty of the Department of Microbiology at Dartmouth Medical School in 1999

Programs:
Immunology Program
Molecular and Cellular Biology Graduate Programs
Molecular Pathogenesis Program

Websites:
http://dms.dartmouth.edu/microbio/
http://www.dartmouth.edu/~molpath/
http://dms.dartmouth.edu/mcb/
http://www.dartmouth.edu/~gotoole/

Contact Information:

Dartmouth Medical School
Vail Building - HB 7550
Hanover NH 03755
Phone: 603-650-1248
Fax: 603-650-1318
Email: George.A.Otoole@Dartmouth.Edu


Selected Publications:

 

Leid JG, Kerr M, Selgado C, Johnson C, Moreno G, Smith A, Shirtliff ME, O'Toole GA, Cope EK
Flagellum-mediated biofilm defense mechanisms of Pseudomonas aeruginosa against host-derived lactoferrin.
Infect Immun 2009 Oct; 77(10):4559-66
PMID: 19651866 [PubMed - indexed for MEDLINE]

Khoo X, Hamilton P, O'Toole GA, Snyder BD, Kenan DJ, Grinstaff MW
Directed assembly of PEGylated-peptide coatings for infection-resistant titanium metal.
J Am Chem Soc 2009 Aug 12; 131(31):10992-7
PMID: 19621876 [PubMed - indexed for MEDLINE]

Shanks RM, Kadouri DE, MacEachran DP, O'Toole GA
New yeast recombineering tools for bacteria.
Plasmid 2009 Sep; 62(2):88-97
PMID: 19477196 [PubMed - indexed for MEDLINE]

Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA
Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles.
PLoS Pathog 2009 Apr; 5(4):e1000382
PMID: 19360133 [PubMed - indexed for MEDLINE]

Newell PD, Monds RD, O'Toole GA
LapD is a bis-(3',5')-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0-1.
Proc Natl Acad Sci U S A 2009 Mar 3; 106(9):3461-6
PMID: 19218451 [PubMed - indexed for MEDLINE]

Moreau-Marquis S, O'Toole GA, Stanton BA
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
Am J Respir Cell Mol Biol 2009 Sep; 41(3):305-13
PMID: 19168700 [PubMed - indexed for MEDLINE]

Monds RD, O'Toole GA
The developmental model of microbial biofilms: ten years of a paradigm up for review.
Trends Microbiol 2009 Feb; 17(2):73-87
PMID: 19162483 [PubMed - indexed for MEDLINE]

Zegans ME, Wagner JC, Cady KC, Murphy DM, Hammond JH, O'Toole GA
Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa.
J Bacteriol 2009 Jan; 191(1):210-9
PMID: 18952788 [PubMed - indexed for MEDLINE]

Merritt JH, Kadouri DE, O'Toole GA
Growing and analyzing static biofilms.
Curr Protoc Microbiol 2005 Jul; Chapter 1():Unit 1B.1
PMID: 18770545 [PubMed - indexed for MEDLINE]

Ye S, MacEachran DP, Hamilton JW, O'Toole GA, Stanton BA
Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
Am J Physiol Cell Physiol 2008 Sep; 295(3):C807-18
PMID: 18650266 [PubMed - indexed for MEDLINE]


Professional Interests:

The main focus of the O’Toole laboratory is the study of complex surface-attached bacterial communities known as biofilms. Biofilms can form on a wide variety of surfaces including catheter lines, surgical implants, contact lenses, the lungs of patients with cystic fibrosis, industrial and drinking water pipelines, and on the surfaces of plant roots. In most natural, clinical, and industrial settings bacteria live predominantly in biofilms and not as planktonic (free-swimming) cells such as those typically studied in the laboratory. Bacteria growing in biofilm communities are of great interest to the medical community, because these bacteria become highly resistant to antibiotics by an as yet unknown mechanism. Although much has been learned about the types of microbes that can form biofilms, the morphology of these communities, and their chemical/physical properties, until recently little was known about the molecular genetic basis of biofilm formation or antibiotic resistance.

Studies in the O’Toole lab focus on:
• The molecular genetic basis of biofilm formation.
• The role of the intracellular signaling molecule c-di-GMP in controlling biofilm formation by pseudomonads.
• The signal transduction pathways regulating biofilm formation.
• The mechanisms by which biofilms form on biotic, or living surfaces, and why these biofilms are so highly resistant to antibiotics. We have developed a novel model system for studying biofilms on airway epithelial cells, and these studies are done, in particular, in the context of cystic fibrosis.
• The role of lysogenic phages in impacting biofilm formation.

Recent collaborative studies with Dr. Bruce Stanton’s group here at Dartmouth have explored questions of host-pathogen interactions, using the interplay between the bacterial pathogen Pseudomonas aeruginosa and airway epithelial cells as a model system. We are particularly interested in the role of the toxin, Cif, in altering epithelial cell biology and protein trafficking. We are also studying mechanisms by which P. aeruginosa delivers toxins to host cells.

Please visit the O'Toole Lab Home Page.

Copyright © 2009 Trustees of Dartmouth College

Feedback